Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for neuroendocrine tumors. To learn more about a study, choose from the list below.
For lung cancer clinical trials, visit that section of our Web site.
| Title | Investigator |
|---|---|
|
A Phase III Study of Everolimus versus Placebo in Patients with Neuroendocrine Tumors Originating in the Lungs or Gastrointestinal Tract: The RADIANT-4 Study [Protocol 12-250] |
Reidy-Lagunes, Diane, MD |
